Paid Clinical Trials Vancouver

Discover 685 paid clinical trials in Vancouver. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 685

Norovirus Research for Adults

Recruiting

Phase 3

Sponsor:

Moderna

Location:

Richmond, Seattle, Kelowna, Calgaryshow 151 more

Code:

NCT06592794

Conditions

Acute Gastroenteritis

Norovirus Acute Gastroenteritis

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Accepted

Interventions

mRNA-1403

Placebo

The Frequency of Screening and SBT Technique Trial: The FAST Trial

Recruiting

Sponsor:

Unity Health Toronto

Location:

Vancouver, Edmonton, Los Angeles, Long Beachshow 9 more

Code:

NCT02969226

Conditions

Critically Ill

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

Once daily screening

Twice daily screening

PS SBTs

T-piece SBTs

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Richmond, Kelowna, Spokane, Roseburgshow 195 more

Code:

NCT06283966

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

BGF MDI 320/14.4/9.6 μg

GFF MDI 14.4/9.6 μg

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

Recruiting

PHASE2

Sponsor:

University of British Columbia

Location:

Vancouver, Seattle, Sacramento, Ann Arborshow 5 more

Code:

NCT04812366

Conditions

Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Apalutamide 60mg Tab

Abiraterone Acetate 250mg

Prednisone 5mg Tab

Docetaxel

Niraparib 100mg Oral Capsule

Falls Prevention Clinic

Recruiting

Sponsor:

University of British Columbia

Location:

Vancouver

Code:

NCT01022866

Conditions

Falls

Eligibility Criteria

Sex: All

Age: 70+

Healthy Volunteers: Not accepted

A Study to Evaluate the Efficacy and Safety of Enlicitide Decanoate (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018) CORALreef AddOn

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Vancouver, Renton, Lincoln, Flossmoorshow 8 more

Code:

NCT06450366

Conditions

Hypercholesterolemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Enlicitide Decanoate

Ezetimibe

Bempedoic Acid

Placebo for Enlicitide Decanoate

Placebo for Ezetimibe

Does Teaching Before or After Simulation Improve Learning?

Recruiting

Sponsor:

University of British Columbia

Location:

Vancouver

Code:

NCT06092320

Conditions

Medical Education

Simulation

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Simulation on Pediatric Status Epilepticus

Didactic Lecture on Pediatric Status Epilepticus

Fixed Duration vs Continuous Daratumumab in Transplant Ineligible Older Adults With Newly Diagnosed Multiple Myeloma

Recruiting

PHASE3

Sponsor:

Canadian Cancer Trials Group

Location:

Vancouver, Kelowna, Saskatoon, Reginashow 13 more

Code:

NCT06182774

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Daratumumab

Lenalidomide

Dexamethasone

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Recruiting

PHASE3

Sponsor:

Hoffmann-La Roche

Location:

Vancouver, Sacramento, Salt Lake City, Aurorashow 7 more

Code:

NCT04958265

Conditions

Atypical Hemolytic Uremic Syndrome

Eligibility Criteria

Sex: All

Age: 28 - 17

Healthy Volunteers: Not accepted

Interventions

Crovalimab

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Recruiting

PHASE3

Sponsor:

Bristol-Myers Squibb

Location:

Vancouver, Everett, Seattle, Kelownashow 86 more

Code:

NCT06003426

Conditions

Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

BMS-986278

BMS-986278 Placebo

Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma

Recruiting

EARLY_PHASE1

Sponsor:

Canadian Cancer Trials Group

Location:

Vancouver, Toronto, Kingston, Montreal

Code:

NCT04161248

Conditions

Lymphoma, B-Cell

Eligibility Criteria

Sex: All

Age: 16 - 65

Healthy Volunteers: Not accepted

Interventions

Venetoclax

Rituximab Injection

Rituximab SC

Gemcitabine

Dexamethasone